WeCareJourney is dedicated to the treatment of spinal muscular atrophy (SMA), the number one genetic cause of death for infants. An SMA diagnosis can be overwhelming, and we give patients and families the information and resources they need to live active, engaged, and hopeful lives today. We are committed to respecting and fostering diversity and inclusion in the people we help.
Our Vision
To champion C.A.R.E and support for families with SMA & disabilities.
Our Mission
Caring and Connecting families with SMA and disabilities to support by taking Action and creating Awareness, promoting Readiness and Responsibility, and by Empowering affected families through Education.
Our Vision
To champion C.A.R.E and support for families with SMA & disabilities
Our Mission
Caring and Connecting families with SMA and disabilities to support by taking Action and creating Awareness, promoting Readiness and Responsibility, and by Empowering affected families through Education.
What We Do
Family Support & Empowerment
Our programs provide tangible support for families affected by SMA, easing the difficulties of an SMA diagnosis, and showing each family that they are not alone and that there is hope. Our family support programs also hope to build and maintain a strong and unified community.
The foundation of our family support programs is our outreach. We’re committed to making sure that these families and all our families have the best, most accurate information about SMA and what it means for them, from day-to-day care to the changing landscape of research breakthroughs. In addition, individuals affected by SMA need specialized care and equipment, which can put enormous financial pressure on families. WeCareJourney makes sure families understand all the options and resources available to them, and our equipment pool and service support gives families access to specialized items and education like:
with mechanical insufflation-exsufflation or “cough assist” machines, against pulmonary disease which is the major cause of morbidity and mortalityii, and
with influenza vaccinations for patients, and their care-givers, and
with standing frames, to maintain healthier bone and internal organ development, prevent some muscular issues, and some psychological benefits.
funding for accessibility equipment such as powered wheelchairs, and
parent support groups together with experienced counsellors and speakers, and
talks to guide parents who are SMA carriers on family planning options, and
the Young Adult program which gives them a platform to discover and access opportunities for personal and professional development.
Learning how to care for SMA better
with our local language care guides, and
with medical talks on mechanical insufflation-exsufflation (which is also attended by the medical community to share and to learn), and
with medical talks on clinical trials, and
with medical talks with overseas SMA expert doctors.
Protecting against illnesses
with mechanical insufflation-exsufflation or “cough assist” machines, against pulmonary disease which is the major cause of morbidity and mortality, and
with influenza vaccinations for patients, and their care-givers, and
with standing frames, to maintain healthier bone and internal organ development, prevent some muscular issues, and some psychological benefits.
Empowering patients and care-givers
funding for accessibility equipment such as powered wheelchairs, and
parent support groups together with experienced counsellors and speakers, and
talks to guide parents who are SMA carriers on family planning options, and
the Young Adult program which gives them a platform to discover and access opportunities for personal and professional development.
Awareness & Advocacy
WeCareJourney regularly acts to raise awareness on SMA at digital and traditional media, and at real world events and campaigns which we participate in or organise ourselves. Where possible we provide platforms and give opportunities for patients and care-givers to have a voice. To-date, we have reached over a million people, often with the support of partners in government, corporate, media and individuals, to spread awareness.
It is equally important to help prevent SMA, and by referring people who wish to find out more, to carrier testing, affordable genetic counselling and be directed to specialists who can advise on ways to reduce the risk of having a baby with SMA.
On December 23, 2016, the United States Food and Drug Administration announced that it had approved Spinraza, the first-ever approved drug therapy for SMA. The time that have followed this ground-breaking announcement have been filled with celebration and hope for the future. But it has also been a time of frustration with many countries fighting to get access and funding for this costly drug. The situation in Malaysia remains extremely difficult. We are committed to advocacy and to motivate stakeholders to take proper action to uphold the right to life and resolve the inequity. At the same time, we drive hard to strengthen relationships with relevant biotech and pharmaceutical companies to run clinical trials here, or to get Malaysian patients recruited into trials overseas (one has been successful). We believe that all stakeholders share common objectives and should collaborate, and we hope to catalyse this “can-do-together” attitude by continuously championing for better care and support with the programs we run.
Thank you! Your contribution, BIG or SMALL makes a huge difference!
We accept donation in the following form:
PERSATUAN KEBAJIKAN CERIAJAYA KUALA LUMPUR DAN SELANGOR (WECAREJOURNEY)
Maybank Account Number: 512231392941
Alternatively, you may scan this QR code to pay using Maybank App:
Please email us your full name and contact details so we can give you an official receipt: hello@wecarejourney.org
